Skip to main content

Reversal of Respiratory Failure in Both Neonatal and Late Onset Isolated Remethylation Disorders

  • Case Report
  • Chapter
  • First Online:

Part of the book series: JIMD Reports ((JIMD,volume 16))

Abstract

Respiratory failure is a well-documented potential presentation of inherited isolated remethylation disorders (IRDs). It appears to be a combination of both central and peripheral neuropathy and has previously often been considered to herald an irreversible neurological decline. We present three patients, one with methionine synthase (cblG) and two with methyltetrahydrofolate reductase deficiency (MTHFR). One patient with MTHFR presented in infancy, and other patients in later childhood. All three patients required intubation for respiratory failure but in all three, this was totally reversed by the initiation of medical therapy. This consisted of betaine and folinic acid supplementation in all three, methionine in two and cobalamin supplementation in two. The rate of respiratory improvement was variable, though two of the cases were successful extubated within a week of commencement of medical therapy. We document their subsequent clinical, biochemical and electrophysiological progress and review the potential pathological mechanisms underlying respiratory failure in these disorders.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abeling NG, van Gennip AH, Blom H et al (1999) Rapid diagnosis and methionine administration: basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency. J Inherit Metab Dis 22:240–242

    Article  CAS  PubMed  Google Scholar 

  • Al Tawari AA, Ramadan DG, Neubauer D, Heberle LC, Al AF (2002) An early onset form of methylenetetrahydrofolate reductase deficiency: a report of a family from Kuwait. Brain Dev 24:304–309

    Article  PubMed  Google Scholar 

  • Al-Essa MA, Al AA, Rashed M et al (1999) Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency. Brain Dev 21:345–349

    Article  CAS  PubMed  Google Scholar 

  • Amur SG, Shanker G, Cochran JM, Ved HS, Pieringer RA (1986) Correlation between inhibition of myelin basic protein (arginine) methyltransferase by sinefungin and lack of compact myelin formation in cultures of cerebral cells from embryonic mice. J Neurosci Res 16:367–376

    Article  CAS  PubMed  Google Scholar 

  • Baethmann M, Wendel U, Hoffmann GF et al (2000) Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics 31:314–317

    Article  CAS  PubMed  Google Scholar 

  • Chaabene-Masmoudi A, Mesrati F, Zittoun J, Landrieu P (2009) Insidious peripheral neuropathy occurring under treatment in infantile MTHFR deficiency. J Inherit Metab Dis 32(Suppl 1):S303–S306

    Article  PubMed  Google Scholar 

  • Clayton PT, Smith I, Harding B, Hyland K, Leonard JV, Leeming RJ (1986) Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 49:920–927

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dayal S, Bottiglieri T, Arning E et al (2001) Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 88:1203–1209

    Article  CAS  PubMed  Google Scholar 

  • de la Haba G, Cantoni GL (1959) The enzymatic synthesis of S-adenosyl-l-homocysteine from adenosine and homocysteine. J Biol Chem 234:603–608

    Google Scholar 

  • de Ogier BH, Gerard M, Saudubray JM, Zittoun J (1998) Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 157(Suppl 2):S77–S83

    Article  Google Scholar 

  • Debray FG, Boulanger Y, Khiat A et al (2008) Reduced brain choline in homocystinuria due to remethylation defects. Neurology 71:44–49

    Article  CAS  PubMed  Google Scholar 

  • Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM (2014) Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurol 71:188–194

    Article  PubMed  Google Scholar 

  • Haworth JC, Dilling LA, Surtees RA et al (1993) Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 45:572–576

    Article  CAS  PubMed  Google Scholar 

  • Katz JE, Dlakic M, Clarke S (2003) Automated identification of putative methyltransferases from genomic open reading frames. Mol Cell Proteomics 2:525–540

    CAS  PubMed  Google Scholar 

  • Kishi T, Kawamura I, Harada Y et al (1994) Effect of betaine on S-adenosylmethionine levels in the cerebrospinal fluid in a patient with methylenetetrahydrofolate reductase deficiency and peripheral neuropathy. J Inherit Metab Dis 17:560–565

    Article  CAS  PubMed  Google Scholar 

  • Narisawa K, Wada Y, Saito T, Suzuki H, Kudo M (1977) Infantile type of homocystinuria with N5,10-methylenetetrahydrofolate reductase defect. Tohoku J Exp Med 121:185–194

    Article  CAS  PubMed  Google Scholar 

  • Nishimura M, Yoshino K, Tomita Y et al (1985) Central and peripheral nervous system pathology of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr Neurol 1:375–378

    Article  CAS  PubMed  Google Scholar 

  • Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J (1994) Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57:765–766

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rosenblatt DS, Fenton WA (2001) Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, beaudet AL, Valle D, Sly WS (eds) The metabolic and molecular basis of disease. Mcgraw-Hill, New York, Chap 155, pp 3897–3923

    Google Scholar 

  • Schatz RA, Wilens TE, Sellinger OZ (1981) Decreased in vivo protein and phospholipid methylation after in vivo elevation of brain S-adenosyl-homocysteine. Biochem Biophys Res Commun 98:1097–1107

    Article  CAS  PubMed  Google Scholar 

  • Schiff M, Benoist JF, Tilea B, Royer N, Giraudier S, de Ogier BH (2011) Isolated remethylation disorders: do our treatments benefit patients? J Inherit Metab Dis 34:137–145

    Article  CAS  PubMed  Google Scholar 

  • Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157(Suppl 2):S118–S121

    Article  CAS  PubMed  Google Scholar 

  • Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:1550–1554

    Article  CAS  PubMed  Google Scholar 

  • Tonetti C, Saudubray JM, Echenne B, Landrieu P, Giraudier S, Zittoun J (2003) Relations between molecular and biological abnormalities in 11 families from siblings affected with methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 162:466–475

    Article  PubMed  Google Scholar 

  • Tsuji M, Takagi A, Sameshima K et al (2011) 5,10-Methylenetetrahydrofolate reductase deficiency with progressive polyneuropathy in an infant. Brain Dev 33:521–524

    Article  PubMed  Google Scholar 

  • Weir DG, Scott JM (1995) The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol 8:479–497

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the contribution of Professor B Fowler and the University Children’s hospital Zurich for the fibroblast work on patients 1 and 2 and Dr Rodenburg and Prof Van Den Heuvel at the Stichting klinisc- Genetisch Centrum Nijmegen for their work on patient 3.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Broomfield .

Editor information

Editors and Affiliations

Additional information

Communicated by: Garry Brown

Appendices

Synopsis

Acute respiratory failure seen in remethylation disorders is multifactorial but with aggressive medical management can be reversed.

Compliance with Ethics Guidelines

Alexander Broomfield, Lara Abulhoul, Matthew Pitt, Elisabeth Jameson and Maureen Cleary declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.

Contributions of Each Author

Dr Broomfield conception and design of study, draft article. Dr Abulhoul revision of article and collection of data. Dr Jameson design of article and revision. Dr Pitt analysis and interpretation of data. Dr Cleary revision of article and provision of data.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Broomfield, A., Abulhoul, L., Pitt, W., Jameson, E., Cleary, M. (2014). Reversal of Respiratory Failure in Both Neonatal and Late Onset Isolated Remethylation Disorders. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports Volume 16. JIMD Reports, vol 16. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2014_319

Download citation

  • DOI: https://doi.org/10.1007/8904_2014_319

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44586-0

  • Online ISBN: 978-3-662-44587-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics